Sold as Liquamar. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Phenprocoumon (sold as Liquamar), first approved Dec 30, 1957, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Dec 30, 1957 | LiquamarNDA 11228 ยท New formulation or manufacturer | Organon USA Inc | 3 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
